To satisfy Open Payment mandates a great deal of information must be collected, verified, validated and organized. At events, meeting managers must record every transaction in a way that facilitates assignment to multiple participants. Attendance details must be thoroughly recorded for the main event as well as any sub-event. Attendee identities should be validated and include NPI numbers (and, depending on other technology, state license information). Ultimately, attendance and spending information must be properly stored and organized to satisfy various (and frequently changing) compliance regulations while making it available for an audit at any time. This article by Ross Dworkin …
mars, 2016
-
10 mars
Lutte contre la corruption et le trafic d’influence ou FCPA “à la française”
Sébastien Pradeau, spécialiste du droit de la santé et membre du Think Tank Loi Bertrand, fait un point sur le projet de loi relatif à la lutte contre la corruption et à la transparence de la vie économique, dit projet de loi “Sapin II” qui sera présenté en Conseil des Ministres, le 23 mars 2016.
février, 2016
-
29 février
Les Échos | Base Transparence Santé : où en est-on ?
Le point sur cette base qui permet de rechercher les liens d’intérêts entre industries de santé et praticiens, un an après la décision du Conseil d’État qui invitait à aller plus loin. La base doit permettre de présenter « de manière objective les liens » unissant industries de santé et praticiens, et permettre au citoyen « d’apprécier ses liens et de s’en faire une opinion », explique-t-on au ministère. Mais une fois que le citoyen a pris connaissance de ces liens d’intérêts, comment savoir s’ils sont suspects ? Interrogé sur l’ouverture d’éventuelles enquêtes depuis le lancement de la base, le ministère de la Santé …
-
29 février
Disclosure of drug company payments to healthcare professionals is on its way in the UK — a big step towards transparency
Around £40m is paid to healthcare professionals in the UK each year by pharmaceutical companies. These payments are unidentifiable, made available on an aggregate basis. However, from 30 June 2016, for the first time patients will be able find out if their doctor, pharmacist or other healthcare professional has received any payments from a pharmaceutical company. The payments, which could include being paid to attend a medical event or acting as an adviser to a pharmaceutical or medical device company, will be listed on a publicly searchable database called Disclosure UK. This will be hosted by the Association of British …
-
29 février
Open Payments and Continuing Medical Education
A subset of drug, biological, and device manufacturers have raised questions concerning the Physician Payments Sunshine Act (dubbed the Open Payments Program) reporting requirements and participation in commercially-supported accredited and certified continuing medical education (accredited/certified CME) programs in 2016. The following outlines the relevant statutory, regulatory and sub-regulatory guidance issued by the Centers for Medicare and Medicaid Services (CMS) through February 1, 2016. Under the American Medical Association (AMA) CME Credit system standards and Code of Ethics and ACCME accreditation standards, commercial supporters are prohibited from having any direct or indirect influence or control with respect to the content, faculty, …
-
18 février
EDMA and Eucomed Adopt Code of Business Practice Brings Changes to Medical Congresses
By Thomas Sullivan – Policy & Medicine Members of both the European Diagnostic Manufacturers Association (EDMA) and the European Medical Technology Industry (Eucomed) approved a new Code of Ethical Business Practice. Both associations are members of MedTech Europe who are working to set high ethical standards for the medical technology industry all throughout Europe. This new Code will replace the EDMA and Eucomed codes of business practice and will be known as the MedTech Europe Code of Business Practice. This decision to adopt a common and wide-reaching code was prompted by the fact that EDMA and Eucomed each had different …
